Salesforce, which struggled in early 2026 due to concerns that AI would disrupt its SaaS model, reported a strong Q2 FY27 with revenue up 10.8% to $11.35 billion and an 80% EPS beat. The company’s Agentforce product saw ARR grow over 240%, prompting a raised revenue forecast for FY27 and a bullish price target of $363.85, implying nearly 49% upside. While integration risks and non-recurring gains pose caution, the overall outlook is positive, especially if CloudForce adoption and premium upgrades continue. Salesforce’s valuation appears reasonable compared to peers Microsoft and Oracle, supporting a buy recommendation with 90% confidence.
Listen Labs, a startup using voice AI for customer interviews, walked away from a signed $125 million Series C funding round led by Menlo Ventures. The funding likely fell through due to ongoing acquisition talks with Salesforce, which is considering...
Salesforce is in talks to acquire Listen Labs, an AI-powered customer research platform, for about $2 billion. Listen Labs helps companies gather and analyze customer feedback using AI moderators and a global participant network. The deal, if complet...
Salesforce shares trade at $249.12, reflecting a valuation that seems fully priced based on past earnings. However, strong AI-driven growth, especially in its Agentforce segment with annual recurring revenue surpassing $1.5 billion, suggests signific...
Salesforce shares surged 34% after reporting fiscal Q2 earnings with a non-GAAP EPS of $5.90 versus $3.27 expected, largely due to $2.6 billion in net gains from strategic investments contributing $2.53 per share. Excluding these gains, recurring ear...
Investors pulled $700 million from the iShares Expanded Tech-Software Sector ETF (IGV) just hours before Snowflake reported a strong quarter with 37% product revenue growth and an increased full-year forecast, driven partly by AI. Despite Snowflake's...
